Please provide your email address to receive an email when new articles are posted on . “Because there are no permanent adverse reactions or deforming reactions, I think the safety is assured,” Karen ...
IRVINE, Calif.--(BUSINESS WIRE)--Allergan, Inc., (NYSE: AGN) is pleased that the U.S. Food and Drug Administration (FDA) General and Plastic Surgery Devices Panel of the Medical Devices Advisory ...
There's no denying it: plastic surgery is a big commitment. First and foremost, whether the procedure is small or large, it's still making a (most likely) permanent change to your body, which is ...
(RTTNews) - Allergan plc (AGN) said that it received U.S. Food and Drug Administration approval for the use of Juvéderm VOLUMA XC, a hyaluronic acid gel dermal filler, with a TSK STERiGLIDE cannula ...
A US Food and Drug Administration (FDA) panel today unanimously recommended that the agency approve Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the mid-face. Juvéderm ...
The US Food and Drug Administration (FDA) has approved Juvéderm Voluma XC (Allergan) to correct age-related volume deficits in the midface in adults aged 21 years and older, the company announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results